LON:ONT Oxford Nanopore Technologies (ONT) Share Price, News & Analysis → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free ONT Stock Alerts GBX 113.70 +0.80 (+0.71%) (As of 05/10/2024 ET) Add Compare Share Share Today's Range 112.20▼ 116.4050-Day Range 92.75▼ 148.2052-Week Range 91.24▼ 279Volume714,331 shsAverage Volume1.09 million shsMarket Capitalization£980.76 millionP/E RatioN/ADividend YieldN/APrice TargetGBX 303.75 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades Get Oxford Nanopore Technologies alerts: Email Address Oxford Nanopore Technologies MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside167.2% UpsideGBX 303.75 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingAcquiring Shares£7.51 M Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.38 out of 5 stars 3.5 Analyst's Opinion Consensus RatingOxford Nanopore Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageOxford Nanopore Technologies has only been the subject of 2 research reports in the past 90 days.Read more about Oxford Nanopore Technologies' stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for ONT. Previous Next 0.0 Dividend Strength Dividend YieldOxford Nanopore Technologies does not currently pay a dividend.Dividend GrowthOxford Nanopore Technologies does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ONT. Previous Next 0.6 News and Social Media Coverage Search InterestOnly 1 people have searched for ONT on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat Follows6 people have added Oxford Nanopore Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 500% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Oxford Nanopore Technologies insiders have bought more of their company's stock than they have sold. Specifically, they have bought £75,056.36 in company stock and sold GBX 0 in company stock.Percentage Held by Insiders29.98% of the stock of Oxford Nanopore Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 38.53% of the stock of Oxford Nanopore Technologies is held by institutions.Read more about Oxford Nanopore Technologies' insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Oxford Nanopore Technologies is -598.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Oxford Nanopore Technologies is -598.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOxford Nanopore Technologies has a P/B Ratio of 1.50. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Oxford Nanopore Technologies Stock (LON:ONT)Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company operates in Life Science Research Tools and Covid Testing segments. It offers MinION, a portable device for DNA and RNA; GridION, a flexible and self-contained benchtop nanopore sequencer to run and analyse up to five MinION or Flongle flow cells; MinION Mk 1C, a nano pore-based sequencer with analysis software and connectivity for self-contained and portable sequencing; Flongle, an adapter for MinION or GridION that enables DNA sequencing or cDNA sequencing on smaller and single-use flow cells; and PromethION 2 Solo, a sequencer for two PromethION flow cells. The company also provides PromethION 2, a self-contained benchtop nanopore sequencer; PromethION 24, which provides single or multiple users with access to terabases of sequencing data; PromethION 48, a sequencing device with high-output flow cells; VolTRAX, an automated library prep for nanopore analyses; and Q-Line, a sequencing for applied applications, as well as products for SAR-Cov-2 testing. Its platform enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom.Read More ONT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ONT Stock News HeadlinesMay 2, 2024 | insidertrades.comOxford Nanopore Technologies plc (LON:ONT) Insider Purchases £24,977.84 in StockApril 12, 2024 | insidertrades.comOxford Nanopore Technologies plc (LON:ONT) Insider Acquires £149.50 in StockMay 11, 2024 | Crypto Swap Profits (Ad)Did You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.May 2, 2024 | americanbankingnews.comOxford Nanopore Technologies plc (LON:ONT) Insider Kate Priestman Purchases 23,564 SharesApril 30, 2024 | uk.finance.yahoo.comIndia's SEBI says foreign funds at GIFT City can take full investment from non-resident IndiansMarch 9, 2024 | finance.yahoo.comOxford Nanopore Technologies plc (LON:ONT) Consensus Forecasts Have Become A Little Darker Since Its Latest ReportMarch 7, 2024 | lse.co.ukOxford Nanopore confident in future opportunities despite weak 2023March 7, 2024 | lse.co.ukDIRECTOR DEALINGS: Oxford Nanopore Technologies top team buys sharesMay 11, 2024 | Crypto Swap Profits (Ad)Did You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.February 6, 2024 | msn.comProtecting crops through nanotechnology in Southeast AsiaJanuary 12, 2024 | barrons.comOxford Nanopore Technologies PLC ADRNovember 14, 2023 | tmcnet.comOxford Nanopore and Day Zero Diagnostics Partner to Develop a New Class of Bloodstream Infection DiagnosticsNovember 8, 2023 | morningstar.comOxford Nanopore Technologies PLC ONTTFOctober 23, 2023 | msn.comOxford Nanopore secures £70m from French diagnostics companyOctober 19, 2023 | msn.comOxford Nanopore shares rise sharply amid £70m investmentOctober 19, 2023 | msn.comOxford Nanopore secures £70m investment from French biotech groupSeptember 6, 2023 | marketwatch.comOxford Nanopore Technologies Backs Full-Year View Despite Widened 1H Pretax LossAugust 1, 2023 | seekingalpha.comONTTF Oxford Nanopore Technologies plcAugust 1, 2023 | finance.yahoo.comOxford Nanopore Technologies (LON:ONT) Is In A Strong Position To Grow Its BusinessJuly 19, 2023 | thetimes.co.ukRevenue injection booster for Oxford NanoporeJuly 17, 2023 | marketwatch.comOxford Nanopore Technologies Expects Strong 1H Underlying Revenue GrowthJuly 17, 2023 | lse.co.ukOxford Nanopore maintains outlook after "strong" half-year growthJune 12, 2023 | lse.co.ukOxford Nanopore Technologies launches Germany-based rare-disease studyMarch 21, 2023 | finance.yahoo.comOxford Nanopore open to possibility of overseas listingMarch 21, 2023 | marketwatch.comOxford Nanopore 2022 Losses Narrow on Higher Revenue, Lower ExpensesSeptember 9, 2022 | uk.finance.yahoo.comOxford Nanopore Technologies plc (ONT.L)July 11, 2022 | marketwatch.comOxford Nanopore Technologies Sells Stake in Headquarters for GBP42.5 MlnSee More Headlines Receive ONT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oxford Nanopore Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:ONT CUSIPN/A CIKN/A Webnanoporetech.com Phone44 84 5034 7900FaxN/AEmployees1,238Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 303.75 High Stock Price TargetGBX 355 Low Stock Price TargetGBX 210 Potential Upside/Downside+167.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)GBX (0.19) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-154,510,000.00 Net Margins-91.06% Pretax MarginN/A Return on Equity-23.10% Return on Assets-13.17% Debt Debt-to-Equity Ratio6.47 Current Ratio5.01 Quick Ratio6.01 Sales & Book Value Annual Sales£169.67 million Price / Sales5.78 Cash FlowGBX 28.14 per share Price / Cash Flow4.04 Book ValueGBX 76 per share Price / Book1.50Miscellaneous Outstanding Shares862,590,000Free FloatN/AMarket Cap£980.76 million OptionableNot Optionable Beta0.59 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesDr. Gurdial Singh Sanghera (Age 63)Co-Founder, CEO & Non-Executive Director Comp: $1.59MMr. Timothy Cowper (Age 59)COO & Director Comp: $894.98kDr. James Spike WillcocksChief Strategy Officer & DirectorProf. Hagan Bayley Ph.D.Co-Founder & Member of Technical Advisory BoardMr. Nicholas Patrick Keher (Age 42)CFO & Director Mr. Jordan HermanSenior VP & General CounselMr. John SchoellermanSenior Vice President of Corporate & Business DevelopmentMr. Richard ComptonSenior Vice President of Sales & Commercial OperationsMs. Sara Agee LeVice President of Global MarketingMs. Sarah LapworthSenior Vice President of Global Human ResourcesMore ExecutivesKey CompetitorsErgomedLON:ERGOGenusLON:GNSPureTech HealthLON:PRTCSilence TherapeuticsLON:SLNOxford BiomedicaLON:OXBView All CompetitorsInsidersKate PriestmanBought 23,564 shares on 4/30/2024Total: £2.50 M ($106.00/share)Nick KeherBought 130 shares on 4/11/2024Total: £14,950.00 ($115.00/share)Gurdial (Gordon) SangheraBought 39,196 shares on 3/6/2024Total: £4.98 M ($127.00/share)Timothy CowperBought 95 shares on 2/13/2024Total: £15,010.00 ($158.00/share)James (Spike) WillcocksBought 5,560 shares on 1/11/2024Total: £984,120.00 ($177.00/share)View All Insider Transactions ONT Stock Analysis - Frequently Asked Questions Should I buy or sell Oxford Nanopore Technologies stock right now? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Oxford Nanopore Technologies in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ONT shares. View ONT analyst ratings or view top-rated stocks. What is Oxford Nanopore Technologies' stock price target for 2024? 5 brokerages have issued 1 year price targets for Oxford Nanopore Technologies' shares. Their ONT share price targets range from GBX 210 to GBX 355. On average, they predict the company's stock price to reach GBX 303.75 in the next twelve months. This suggests a possible upside of 167.2% from the stock's current price. View analysts price targets for ONT or view top-rated stocks among Wall Street analysts. How have ONT shares performed in 2024? Oxford Nanopore Technologies' stock was trading at GBX 208.20 at the beginning of 2024. Since then, ONT stock has decreased by 45.4% and is now trading at GBX 113.70. View the best growth stocks for 2024 here. How do I buy shares of Oxford Nanopore Technologies? Shares of ONT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:ONT) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeCollapse of the Petrodollar Colonial MetalsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Nanopore Technologies plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.